Once Weekly Dulaglutide Therapy in Type 2 Diabetic Subjects, Real-world Evidence from a Tertiary Care Diabetes Center in India

AIMS: To evaluate the real-world efficacy, durability, and side-effect profile of once weekly GLP1RA: dulaglutide in Indian type 2 diabetes mellitus (T2DM) patients. MATERIALS AND METHODS: A retrospective observational study. Data for efficacy (HbA1c and weight), adherence/discontinuation and patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasir, Jasjeet S., Mithal, Ambrish, Agarwal, Paras, Mittal, Apeksha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330857/
https://www.ncbi.nlm.nih.gov/pubmed/30766809
http://dx.doi.org/10.4103/ijem.IJEM_424_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330857/
https://www.ncbi.nlm.nih.gov/pubmed/30766809
http://dx.doi.org/10.4103/ijem.IJEM_424_18

Ejemplares similares